Sou Miyake

Head, Venture Investments CSB

Dr. Sou Miyake leads venture investments at CSB, focusing on microbiome innovation and health security. He holds a PhD in molecular microbiology and has a diverse background spanning scientific research, management consulting at L.E.K., and strategic roles in e-commerce and life sciences. Sou previously worked at Temasek Life Sciences Laboratory and Shopee, bringing a unique blend of technical expertise and business strategy to his investment approach. At CSB, he supports startups developing cutting-edge solutions in microbiome science and biotechnology.

Seminars

Wednesday 28th January 2026
Panel Discussion: Rebuilding Investor Confidence in Microbiome Therapeutics to Unlock Capital
3:30 pm
  • Highlight data-driven milestones that attract funding to unlock capital
  • Structure deals to balance risk and reward for early-stage ventures to improve term-sheet appeal
  • Position platforms for scalability and exit potential to attract strategic investment
Wednesday 28th January 2026
Emerging Innovators Showcase: Live Pitches & Strategic Feedback
4:00 pm

This dynamic session offers a platform for early-stage microbiome companies to pitch their technologies to a panel of investors, pharma scouts, and industry experts. Designed to foster visibility, feedback, and potential partnerships, each presentation is followed by live commentary and audience engagement.

Sou Miyake - CSB